Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Penfluridol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Penfluridol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Penfluridol. |
| Buprenorphine | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Hydrocodone | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Penfluridol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Penfluridol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Mirtazapine | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Orphenadrine | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Rotigotine | Penfluridol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Penfluridol. |
| Sodium oxybate | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Thalidomide | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Penfluridol may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Penfluridol is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Penfluridol is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Penfluridol. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Penfluridol. |
| Sulpiride | Penfluridol may increase the antipsychotic activities of Sulpiride. |
| Cimetidine | The serum concentration of Penfluridol can be increased when it is combined with Cimetidine. |
| Clopidogrel | The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Penfluridol. |
| Efavirenz | The serum concentration of Penfluridol can be decreased when it is combined with Efavirenz. |
| Melatonin | The therapeutic efficacy of Penfluridol can be decreased when used in combination with Melatonin. |
| Nafcillin | The therapeutic efficacy of Penfluridol can be decreased when used in combination with Nafcillin. |
| Nitroprusside | Penfluridol may increase the hypotensive activities of Nitroprusside. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Penfluridol. |
| Mequitazine | Penfluridol may increase the arrhythmogenic activities of Mequitazine. |
| Dantrolene | The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Penfluridol. |
| Lithium citrate | The risk or severity of adverse effects can be increased when Penfluridol is combined with Lithium citrate. |
| Lithium carbonate | The risk or severity of adverse effects can be increased when Penfluridol is combined with Lithium carbonate. |
| Lithium hydroxide | The risk or severity of adverse effects can be increased when Penfluridol is combined with Lithium hydroxide. |
| Boceprevir | The serum concentration of Penfluridol can be increased when it is combined with Boceprevir. |
| Ethanol | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Penfluridol. |
| Zimelidine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Fluvoxamine. |
| Duloxetine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Penfluridol is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Sibutramine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Penfluridol is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Penfluridol. |
| Indalpine | The risk or severity of adverse effects can be increased when Penfluridol is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Penfluridol is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Penfluridol is combined with Alaproclate. |
| Tocainide | Tocainide may increase the arrhythmogenic activities of Penfluridol. |
| Aprindine | Aprindine may increase the arrhythmogenic activities of Penfluridol. |
| Xylometazoline | Xylometazoline may increase the arrhythmogenic activities of Penfluridol. |
| Sparteine | Sparteine may increase the arrhythmogenic activities of Penfluridol. |
| Fasudil | Fasudil may increase the arrhythmogenic activities of Penfluridol. |
| Spiradoline | Spiradoline may increase the arrhythmogenic activities of Penfluridol. |
| Tiracizine | Tiracizine may increase the arrhythmogenic activities of Penfluridol. |
| Ethacizine | Ethacizine may increase the arrhythmogenic activities of Penfluridol. |
| Hydroquinine | Hydroquinine may increase the arrhythmogenic activities of Penfluridol. |
| Carteolol | Penfluridol may increase the arrhythmogenic activities of Carteolol. |
| Metipranolol | Penfluridol may increase the arrhythmogenic activities of Metipranolol. |
| Bioallethrin | Penfluridol may increase the arrhythmogenic activities of Bioallethrin. |
| Fosfructose | Penfluridol may increase the arrhythmogenic activities of Fosfructose. |
| Hydroquinidine | Penfluridol may increase the arrhythmogenic activities of Hydroquinidine. |
| SOR-C13 | Penfluridol may increase the arrhythmogenic activities of SOR-C13. |
| Digoxin | Digoxin may increase the arrhythmogenic activities of Penfluridol. |
| Acetyldigitoxin | Acetyldigitoxin may increase the arrhythmogenic activities of Penfluridol. |
| Deslanoside | Deslanoside may increase the arrhythmogenic activities of Penfluridol. |
| Cymarin | Cymarin may increase the arrhythmogenic activities of Penfluridol. |
| Metildigoxin | Metildigoxin may increase the arrhythmogenic activities of Penfluridol. |
| Acetyldigoxin | Acetyldigoxin may increase the arrhythmogenic activities of Penfluridol. |
| Disopyramide | Disopyramide may increase the arrhythmogenic activities of Penfluridol. |
| Ibutilide | Ibutilide may increase the arrhythmogenic activities of Penfluridol. |
| Procainamide | Procainamide may increase the arrhythmogenic activities of Penfluridol. |
| Bepridil | Bepridil may increase the arrhythmogenic activities of Penfluridol. |
| Terodiline | Terodiline may increase the arrhythmogenic activities of Penfluridol. |
| Diltiazem | Diltiazem may increase the arrhythmogenic activities of Penfluridol. |
| Nimodipine | Nimodipine may increase the arrhythmogenic activities of Penfluridol. |
| Cinnarizine | Cinnarizine may increase the arrhythmogenic activities of Penfluridol. |
| Atropine | Atropine may increase the arrhythmogenic activities of Penfluridol. |
| Adenosine | Adenosine may increase the arrhythmogenic activities of Penfluridol. |
| Levosimendan | Levosimendan may increase the arrhythmogenic activities of Penfluridol. |
| Nifedipine | Nifedipine may increase the arrhythmogenic activities of Penfluridol. |
| Flecainide | Flecainide may increase the arrhythmogenic activities of Penfluridol. |
| Prenylamine | Prenylamine may increase the arrhythmogenic activities of Penfluridol. |
| Azimilide | Azimilide may increase the arrhythmogenic activities of Penfluridol. |
| Tedisamil | Tedisamil may increase the arrhythmogenic activities of Penfluridol. |
| Nilvadipine | Nilvadipine may increase the arrhythmogenic activities of Penfluridol. |
| Fendiline | Fendiline may increase the arrhythmogenic activities of Penfluridol. |
| Benidipine | Benidipine may increase the arrhythmogenic activities of Penfluridol. |